Antibody News and Research

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

EMEA's CHMP recommends approval of Merck's ELONVA

20. November 2009 08:52

Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. [More]

6bf91f5b-3469-4016-af69-65b302f579e3|0|.0

Posted in: Drug Trial News | Women's Health News

Tags: Antibody, Endometriosis, Fertility, Gonadotropin, Headache, Infertility, IVF, Nausea, Pregnancy, Sperm

Inovio Biomedical announces positive test results of its consensus influenza vaccines

20. November 2009 06:39

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. [More]

5ea790c2-653b-41a5-a70d-b25aa6cc161b|0|.0

Posted in: Drug Trial News | Pharmaceutical News

Tags: Antibody, Avian Influenza, Cancer, Cervical Cancer, DNA, Gene Expression, H1N1, H3N2, H5N1, Influenza, Pandemic, Swine Flu, Vaccine, Virus

Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine

20. November 2009 02:59

New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. [More]

33b4a11b-7ade-4efb-9254-5364e24423bd|0|.0

Posted in: Disease/Infection News | Pharmaceutical News

Tags: Allergy, Antibody, Health and Human Services, Vaccine, Virus

US and European market for radiopharmaceuticals continues to gain momentum

20. November 2009 02:41

Research and Markets (http://www.researchandmarkets.com/research/410c60/radiopharmaceutica) has announced the addition of the "Radiopharmaceuticals - A US and European Market Analysis" report to their offering. [More]

695b9412-1af5-4d8a-a9fc-d0801585eab5|0|.0

Posted in: Pharmaceutical News

Tags: Antibody, Brain, Brain Cancer, Cancer, Cell, Ciprofloxacin, Follicular Lymphoma, Lung Cancer, Lymphoma, Nephrology, Neurology, Nuclear Medicine, Oncology, Radiation Therapy, Radiotherapy, Zevalin

Comprehensive report on world cancer therapies market

20. November 2009 01:37

Research and Markets (http://www.researchandmarkets.com/research/4b82d8/cancer_therapies) has announced the addition of the "Cancer Therapies - Global Market Opportunities" report to their offering. [More]

d1ec933e-6b16-4c92-bf1f-1cae23f4af72|0|.0

Posted in: Device / Technology News

Tags: Abraxane, Antibody, Avastin, Bone, Bone Marrow, Cancer, Cell, Chemotherapy, Colorectal Cancer, Diabetes, Drug Delivery, Gemzar, Genetics, Genomics, Hormonal Therapy, Immunization, Immunotherapy, Pfizer, Proteomics, Radiation Therapy, Smoking, Stem Cell, Tarceva, Taxotere, Xeloda

Sugar-coated polymer may offer a new solution for allergy and asthma

20. November 2009 01:36

Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Their advance is a significant step toward crafting pharmaceuticals to fight these often life-endangering conditions in a new way. [More]

2a6f7ef8-183d-420d-92fc-527846075780|0|.0

Posted in: Medical Science News | Medical Condition News

Tags: Allergy, Antibody, Asthma, Cell, Immunology, Pharmacology

TGen Drug Development and IPC collaborate to speed up research discoveries for cancer patients

20. November 2009 01:29

TGen Drug Development (TD2) and the Institut Paoli-Calmettes (IPC) have forged a strategic alliance that will enable both to maximize their worldwide contributions in the treatment of cancer patients. [More]

2f2603db-409c-4a0e-a2e0-3705a46f9933|0|.0

Posted in: Medical Condition News | Healthcare News

Tags: Antibody, Biotechnology, Cancer, Diabetes, Education, Genomics, Metastasis, Oncology, Ovarian Cancer, Pancreatic Cancer, Pharmacogenomics

Genetic identity of cellular receptor for the immune system's first-response antibody discovered

19. November 2009 06:00

Researchers at the University of Alabama at Birmingham (UAB) have uncovered the genetic identity of a cellular receptor for the immune system's first-response antibody, a discovery that sheds new light on infection control and immune disorders. The discovery is such a crucial part of immunology that UAB researchers, in conjunction with Japanese researchers, are asking that the gene linked to this antibody receptor be renamed to better describe its role in early immune responses. [More]

92f53590-9348-4048-9089-40da9f16f3dc|0|.0

Posted in: Medical Science News

Tags: Allergy, Antibody, Cancer, Cell, Chronic Lymphocytic Leukemia, DNA, Immunology, Leukemia, Pathology, Virus

FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia

19. November 2009 03:13

Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies’ applications for Rituxan® (rituximab) plus fludarabine and cyclophosphamide (FC) for the treatment of people with previously untreated and previously treated chronic lymphocytic leukemia (CLL). [More]

7169822c-90e7-4db1-bb27-26e0162bbe54|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Anthracycline, Antibody, Arthritis, Biotechnology, Bone, Bone Marrow, Brain, Cancer, Cell, Chemotherapy, Chronic Lymphocytic Leukemia, Cough, Cyclophosphamide, Headache, Hepatitis B, Leukemia, Lymphoma, MabThera, Methotrexate, Multiple Sclerosis, Nausea, Rheumatoid Arthritis, Rituximab, Virus

Researchers develop new device with nano-sized features to grab cancer cells

19. November 2009 02:17

Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. [More]

7c97c4aa-ef53-4795-8567-519131b813e6|0|.0

Posted in: Device / Technology News | Medical Science News | Medical Condition News

Tags: Antibody, Biopsy, Breast Cancer, Cancer, Cell, Metastasis, Nanotechnology, Pathology, Pharmacology, Urology

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

18. November 2009 11:14

CEL-SCI Corporation, a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today the start of the Company's first clinical study for hospitalized H1N1 patients at The Johns Hopkins University School of Medicine (Johns Hopkins). [More]

9aea071e-d167-4928-8ed6-d83f1c119f6b|0|.0

Posted in: Medical Science News | Disease/Infection News

Tags: Antibody, Cancer, Cell, H1N1, H5N1, Head and Neck Cancer, Immunotherapy, Oncology, Pandemic, Stem Cell

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

18. November 2009 06:43

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company's SynCon™ Chikungunya virus DNA vaccine induced protective neutralizing antibody responses in a preclinical non-human primate model. [More]

4319eb60-7e2d-4429-9155-2020c90c7086|0|.0

Posted in: Medical Science News | Disease/Infection News

Tags: Amino Acid, Antibody, Avian Influenza, Cancer, Cell, Cervical Cancer, DNA, Gene Expression, Influenza, Vaccine, Virus

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

18. November 2009 05:12

IBM (IBM) scientists have created a one-step point-of-care-diagnostic test, based on an innovative silicon chip, that requires less sample volume, is significantly faster, portable, easy to use, and can test for many diseases, including one of world's leading causes of death, cardiovascular disease. [More]

8ce0198e-2d36-495d-8092-427c2d4d0ef7|1|5.0

Posted in: Device / Technology News

Tags: Antibody, Antiretroviral, Biotechnology, Breast Cancer, Cancer, Cardiovascular Disease, Dengue Fever, E. coli, Epstein-Barr Virus, Evolution, H1N1, Hepatitis C, Hospital, Influenza, Lung Cancer, Mammography, Microfluidics, Pregnancy, Prostate Cancer, Virus

Press conference highlights emerging treatments in pancreatic cancer

18. November 2009 03:30

As part of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Thompson will moderate a press conference on emerging treatments in pancreatic cancer on Tuesday, Nov. 17, 2009, in Room 202 of the Hynes Convention Center in Boston, Mass., from 1:00 p.m. to 2:00 p.m. ET. [More]

a8f28545-1bf2-426a-9fe3-eefc360e22ae|0|.0

Posted in: Medical Condition News

Tags: Abraxane, Angiogenesis, Antibody, Avastin, Bevacizumab, Blood Vessel, Cancer, Cell, Chemotherapy, Dermatology, Gemcitabine, Gemzar, Gene Expression, Hospital, Liver Cancer, Metastasis, microRNA, Nanotechnology, Oncology, Paclitaxel, Pancreatic Cancer, Pathology, Photodynamic Therapy, Radiotherapy, VEGF

Previous flu infections can reduce the severity of H1N1

18. November 2009 02:09

Researchers at the La Jolla Institute for Allergy & Immunology have found that previous influenza infections may provide at least some level of immunity to the H1N1 "swine" flu. "The question we asked was, "Is the swine flu more like the seasonal flu or like a totally new strain of influenza where there would be no immunity?," said Alessandro Sette, Ph.D., an internationally recognized vaccine expert and director of the La Jolla Institute's Center for Infectious Disease. [More]

09d5d26a-5949-4652-b94d-3313d33b6c2e|0|.0

Posted in: Disease/Infection News

Tags: Allergy, Antibody, Arthritis, Asthma, Cancer, CDC, Cell, Crohn's Disease, Diabetes, H1N1, Immunology, Influenza, Rheumatoid Arthritis, Swine Flu, Vaccine, Virus

<< Previous posts

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Antibody News and Research

EMEA's CHMP recommends approval of Merck's ELONVA

Inovio Biomedical announces positive test results of its consensus influenza vaccines

Discoveries on anti-HIV antibodies may help researchers create an effective HIV vaccine

US and European market for radiopharmaceuticals continues to gain momentum

Comprehensive report on world cancer therapies market

Sugar-coated polymer may offer a new solution for allergy and asthma

TGen Drug Development and IPC collaborate to speed up research discoveries for cancer patients

Genetic identity of cellular receptor for the immune system's first-response antibody discovered

FDA issues complete response for Rituxan, a drug for treating chronic lymphocytic leukemia

Researchers develop new device with nano-sized features to grab cancer cells

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

SynCon Chikungunya virus DNA vaccine induces protective neutralizing antibody responses in animal model

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

Press conference highlights emerging treatments in pancreatic cancer

Previous flu infections can reduce the severity of H1N1

Recent Articles

Free!

Recent Comments

Twitter

Information

Antibody News and Research

Medical News Cloud

Recent Articles